Sophia Sanjay  एक नया लेख बनाया
4 में ·अनुवाद करना

The Quality Debate: A Deep Dive into the Science of Bioequivalence and Public Trust in Generic Drugs | #generic Drugs # Global Market # India # China # Supply Chain

The Quality Debate: A Deep Dive into the Science of Bioequivalence and Public Trust in Generic Drugs

The Quality Debate: A Deep Dive into the Science of Bioequivalence and Public Trust in Generic Drugs

A widespread misconception is that generic drugs are of lower quality than brand-name drugs. A deeper look into the science of bioequivalence reveals why this is a myth and how regulators ensure generics are equally safe and effective.